Forbes Precision Tools approves Q2 results and ₹60 crore capex for capacity expansion
Forbes Precision · Industrial Manufacturing
What the filing says
- Approved unaudited financial results for quarter and half year ended September 30, 2026
- Capital expenditure of ₹60 crore approved for expanding steel taps manufacturing capacity
- Proposed capacity addition of 10 lakh units per annum within 1 to 1.5 years; existing capacity 36 lakh units; utilization 80-92%
Why it's rated notable: the amount is 23% of annual revenue (20% to 50%)
Original filing
Board Meeting Outcome for Outcome Of Board Meeting Held On October 28, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Forbes Precision
- Capex / expansionNotableForbes Precision Tools approves ₹60 crore capital expenditure and Q2 results
Other capex / expansion filings this fortnight
- FLYSBS Aviation inducts Hawker 900XP aircraft to expand operations
- Godawari Power & Ispat receives consent to operate enhanced SMS capacity at Raipur plant
- ACME Solar Holdings reports Q2 FY27 EBITDA ₹874 Cr, PAT ₹269 Cr on consolidated basis
- Sterling Tools reports highest-ever standalone H1FY27 total income and half-yearly EBITDA
- RIR Power Electronics Limited reports Q2 FY27 results with 32.5% revenue growth
- Pitti Engineering Limited Q2 & H1 FY27 earnings call transcript filed with stock exchanges
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Manufacturing
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.